SUSE Valuation

Is SUSE undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SUSE when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SUSE (€10.8) is trading below our estimate of fair value (€12.28)

Significantly Below Fair Value: SUSE is trading below fair value, but not by a significant amount.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for SUSE?

Key metric: As SUSE is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for SUSE. This is calculated by dividing SUSE's market cap by their current revenue.
What is SUSE's PS Ratio?
PS Ratio3x
SalesUS$672.92m
Market CapUS$2.02b

Price to Sales Ratio vs Peers

How does SUSE's PS Ratio compare to its peers?

The above table shows the PS ratio for SUSE vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average5.3x
NABL N-able
4.1x7.0%US$2.0b
BSOFT Birlasoft
2.8x9.6%₹151.1b
NEWGEN Newgen Software Technologies
11.3x21.7%₹146.1b
RPD Rapid7
3x6.7%US$2.5b
SUSE SUSE
3x7.4%€1.9b

Price-To-Sales vs Peers: SUSE is good value based on its Price-To-Sales Ratio (3x) compared to the peer average (5.1x).


Price to Sales Ratio vs Industry

How does SUSE's PS Ratio compare vs other companies in the European Software Industry?

42 CompaniesPrice / SalesEstimated GrowthMarket Cap
SUSE 3.0xIndustry Avg. 2.0xNo. of Companies50PS0246810+
42 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: SUSE is expensive based on its Price-To-Sales Ratio (3x) compared to the European Software industry average (2.3x).


Price to Sales Ratio vs Fair Ratio

What is SUSE's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SUSE PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio3x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate SUSE's Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst SUSE forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentn/a
€14.44
0%
11.2%€16.05€12.82n/a2
Nov ’25n/a
€14.44
0%
11.2%€16.05€12.82n/a2
Oct ’25n/a
€14.44
0%
11.2%€16.05€12.82n/a2
Sep ’25n/a
€14.44
0%
11.2%€16.05€12.82n/a2
Aug ’25n/a
€14.44
0%
11.2%€16.05€12.82n/a2
Jul ’25n/a
€14.44
0%
11.2%€16.05€12.82n/a2
Jun ’25n/a
€14.44
0%
11.2%€16.05€12.82n/a2
May ’25n/a
€14.44
0%
11.2%€16.05€12.82n/a2
Apr ’25n/a
€14.44
0%
11.2%€16.05€12.82n/a2
Mar ’25n/a
€14.44
0%
11.2%€16.05€12.82n/a2
Feb ’25n/a
€14.44
0%
11.2%€16.05€12.82n/a2
Jan ’25n/a
€14.44
0%
11.2%€16.05€12.82n/a2
Dec ’24n/a
€14.44
0%
11.2%€16.05€12.82n/a2
Nov ’24€10.32
€14.86
+44.0%
7.6%€16.43€13.79n/a3
Oct ’24€12.56
€14.41
+14.8%
12.3%€16.88€11.94n/a5
Sep ’24€15.58
€14.41
-7.5%
12.3%€16.88€11.94n/a5
Aug ’24€10.69
€14.20
+32.8%
12.2%€16.51€11.64n/a7
Jul ’24€12.95
€18.75
+44.8%
11.8%€21.40€15.01n/a6
Jun ’24€14.05
€18.96
+35.0%
11.8%€21.69€15.14n/a6
May ’24€17.01
€23.00
+35.2%
9.7%€26.00€19.43n/a7
Apr ’24€16.64
€23.36
+40.4%
9.4%€26.48€19.79n/a7
Mar ’24€18.45
€23.50
+27.4%
10.5%€26.52€19.19n/a7
Feb ’24€17.85
€22.81
+27.8%
9.9%€25.84€18.74n/a7
Jan ’24€16.92
€21.99
+30.0%
11.1%€25.43€17.67n/a7
Dec ’23€19.86
€21.99
+10.7%
11.1%€25.43€17.67n/a7
Nov ’23€17.87
€21.39
+19.7%
11.4%€25.26€17.58€10.327

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.


Discover undervalued companies